Tesis Biosciences’ unique integrated medical platform is revolutionizing targeted genetic sequencing. Precision-based medicine to help treat major chronic diseases.
Our mission is to change medicine by providing physicians, hospitals, and researchers with the tools to help patients treat and overcome major chronic conditions such as heart and lung disease, cancer, diabetes, and Alzheimer’s through advanced genetic testing.
Through our collaborative efforts utilizing our unique processes, we help medical device and pharmaceutical companies bring to market products that improve the quality of life for patients.
Location: United States, Arizona, Phoenix
Employees: 11-50
Phone: +1 855-668-3747
Investors 1
| Date | Name | Website |
| - | Xcellerant... | xcellerant... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 16.03.2022 | Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare... | Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIAB... | hitconsult... |